These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9187827)

  • 1. Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies.
    Hausen B; Morris RE
    Clin Chest Med; 1997 Jun; 18(2):353-66. PubMed ID: 9187827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Brazelton TR; Morris RE
    Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New immunosuppressive agents for organ transplantation.
    Waer M
    Acta Clin Belg; 1997; 52(4):199-203. PubMed ID: 9351290
    [No Abstract]   [Full Text] [Related]  

  • 4. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive approaches to the prevention of graft vascular disease.
    Gregory CR
    Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer immunosuppressive drugs: a review.
    Gummert JF; Ikonen T; Morris RE
    J Am Soc Nephrol; 1999 Jun; 10(6):1366-80. PubMed ID: 10361877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and experimental immunosuppression.
    Castillo Lugo JA
    Bol Asoc Med P R; 1995; 87(5-6):106-8. PubMed ID: 8573248
    [No Abstract]   [Full Text] [Related]  

  • 10. New immunosuppressive regimens in lung transplantation.
    Briffa N; Morris RE
    Eur Respir J; 1997 Nov; 10(11):2630-7. PubMed ID: 9426106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New immunosuppressive drugs and lung transplantation: last or least?
    van den Berg JW; Postma DS; Koëter GH; van der Bij W
    Thorax; 1999 Jun; 54(6):550-3. PubMed ID: 10335012
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
    Miki T; Goller A; Rao A; Wang X; Yin WY; Tandin A; Fung JJ; Starzl TE; Valdivia LA
    Transplant Proc; 1998 Jun; 30(4):1091-2. PubMed ID: 9636444
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinically significant drug interactions with new immunosuppressive agents.
    Mignat C
    Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of tacrolimus and mycophenolate mofetil after cardiac transplantation.
    Taylor DO
    Curr Opin Cardiol; 1997 Mar; 12(2):161-5. PubMed ID: 9192485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
    Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M; Banasik M; Patrzałek D; Klinger M
    Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung transplants with tacrolimus and mycophenolate mofetil: a review.
    Lama R; Santos F; Algar FJ; Alvarez A; Baamonde C
    Transplant Proc; 2003 Aug; 35(5):1968-73. PubMed ID: 12962866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive drugs after lung transplantation.
    Briffa N; Morris RE
    BMJ; 1998 Mar; 316(7133):719-20. PubMed ID: 9529396
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation.
    Zuckermann A; Birsan T; Thaghavi S; Kupilik N; Deviatko E; Dekan G; Wolner E; Klepetko W
    Transplant Proc; 1999; 31(1-2):1160-1. PubMed ID: 10083518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.